发明名称 |
Transvaginal phosphodiesterase inhibitors for infertility treatment |
摘要 |
The present invention relates to a new application of phosphodiesterase inhibitors for couple infertility treatment which forms an effective alternative to the invasive assisted reproductive techniques such as conjugal artificial insemination and which consists of the transvaginal administration of a phosphodiesterase inhibitor immediately before and/or after coitus. It also relates to dosage forms suitable for the intravaginal administration of phosphodiesterase inhibitors. |
申请公布号 |
US9220679(B2) |
申请公布日期 |
2015.12.29 |
申请号 |
US201214128953 |
申请日期 |
2012.06.20 |
申请人 |
PROKREA BCN, S.L. |
发明人 |
Pardina Palleja Maria Carmen;Vaz-Romero Uña Miguel Angel |
分类号 |
A61K31/497;A61K31/52;A61K31/44;A61K31/415;A61K31/40;A61K9/00;A61K9/06;A61K31/437;A61K31/444;A61K31/522;A61K47/32;A61K45/06 |
主分类号 |
A61K31/497 |
代理机构 |
Rothwell, Figg, Ernst & Manbeck P.C. |
代理人 |
Rothwell, Figg, Ernst & Manbeck P.C. |
主权项 |
1. A method of treating infertility in a subject in need thereof, comprising:
administering an effective amount of a pharmaceutical composition comprising a phosphodiesterase inhibitor and at least one pharmaceutically acceptable excipient transvaginally to the subject before and/or after coitus, wherein the pharmaceutical composition is in the form of a gel, ointment or cream. |
地址 |
Barcelona ES |